Exploration of Targeted Anti-tumor Therapy

Published by Open Exploration Publishing Inc.

Open access · CC BY · In DOAJ · United States · Cancer Immunotherapy and Biomarkers

Journal at a glance

ISSN

2692-3114

Publisher

Open Exploration Publishing Inc.

Country

United States

Language

en

License

CC BY

Also known as: Explor Target Antitumor Ther (Abbreviation)

Indexing

• DOAJ: Active
• Scopus: Indexed
• Pubmed: Active

Metrics

Subjects

• Cancer Immunotherapy and Biomarkers
• Cancer Genomics and Diagnostics
• Lung Cancer Treatments and Mutations
• Cancer Cells and Metastasis
• Lung Cancer Research Studies
• Immune cells in cancer
• Immunotherapy and Immune Responses
• Medicine: Internal medicine
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Liquid biopsy in breast cancer: current biomarker platforms and clinical applications (2026)
• Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model (2026)
• Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society (2026)
• Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer (2026)
• Targeting tumor transition windows (2026)

Similar journals

• Cancer Research Communications — United States · Open access · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Genomics and Diagnostics, 5 shared subjects in total, Same country, Same language
• Cancer Discovery — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same country
• Trends in Cancer — United States · — · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total, Same country
• Nature Cancer — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same country
• Lung Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total, Same language
• Journal of Molecular Pathology — Switzerland · Open access · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total, Same language

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05

Journal homepage · Author guidelines